Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Niu, Zheyu ^a   Wang, Mengyi ^a   Zhou, Li ^a   Yao, Lutian ^a   Liao, Quan ^a   Zhao, Yupei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; TUMOR MARKER;

AGED; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR INVASION;

AGED; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 84946222789     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16067     Document Type: Article

References (44)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014
2. Witkowski, E. R., Smith, J. K. & Tseng, J. F. Outcomes following resection of pancreatic cancer. J Surg Oncol 107, 97-103 (2013
3. Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607-620 (2011
4. Winter, J. M., Yeo, C. J. & Brody, J. R. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 107, 15-22 (2013
5. Lee, A. S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67, 3496-3499 (2007
6. Fu, Y. & Lee, A. S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther 5, 741-744 (2006
7. Huang, L. W., Lin, C. Y., Lee, C. C., Liu, T. Z. & Jeng, C. J. Overexpression of GRP78 is associated with malignant transformation in epithelial ovarian tumors. Appl Immunohistochem Mol Morphol 20, 381-3855 (2012
8. Mozos, A. et al. The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma. Am J Pathol 179, 2601-2610 (2011
9. Kuroda, K. et al. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma. Urol Int 87, 450-456 (2011
10. Teng, Y., Ai, Z., Wang, Y., Wang, J. & Luo, L. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma. J Obstet Gynaecol Res 39, 317-325 (2013
11. Zhang, J. et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 23, 401-410 (2006
12. Wu, C. T. et al. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression. Tumour Biol 35, 195-204 (2014
13. Thornton, M. et al. The unfolded protein response regulator GRP78 is a novel predictive biomarker in coloretcal cancer. Int J Cancer 133, 1408-1418 (2013
14. Huang, T. T. et al. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan. J Formos Med Assoc 109, 326-337 (2010
15. Langer, R., Feith, M., Siewert, J. R., Wester, H. J. & Hoefler, H. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 8, 70 (2008
16. Luo, B. & Lee, A. S. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32, 805-18 (2013
17. Su, R. et al. Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 10, 20 (2010
18. Mujumdar, N. et al. Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 306, G1011-20 (2014
19. Raimondi, S., Lowenfels, A. B., Morselli-Labate, A. M., Maisonneuve, P. & Pezzilli, R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24, 349-358 (2010
20. Shkoda, A. et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 132, 190-207 (2007
21. Lin, J. A. et al. Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy. Urol Oncol 32, 29.e1-11 (2014
22. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011
23. Harbour, J. W., Luo, R. X., Dei, S. A., Postigo, A. A. & Dean, D. C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869 (1999
24. Lundberg, A. S. & Weinberg, R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18, 753-761 (1998
25. Srivastava, V., Patel, B., Kumar, M., Shukla, M. & Pandey, M. Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev 14, 2711-2715 (2013
26. Seiler, R., Thalmann, G. N., Rotzer, D., Perren, A. & Fleischmann, A. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod Pathol 27, 87-95 (2014
27. Liang, S. et al. CyclinD1, a prominent prognostic marker for endometrial diseases. Diagn Pathol 8, 138 (2013
28. Wang, H. et al. Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Int J Clin Exp Pathol 7, 264-271 (2014
29. Yamada, S. et al. Epithelial-To-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 154, 946-954 (2013
30. Kang, Y. et al. SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One 9, e107948 (2014
31. O'Connor, K. & Chen, M. Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4, 141-147 (2013
32. Tavares, A. L., Mercado-Pimentel, M. E., Runyan, R. B. & Kitten, G. T. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 235, 1589-98 (2006
33. Wu, Y., Diab, I., Zhang, X., Izmailova, E. S. & Zehner, Z. E. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89. Oncogene 23, 168-178 (2004
34. Raptis, L., Arulanandam, R., Geletu, M. & Turkson, J. The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp Cell Res 317, 1787-1795 (2011
35. Balanis, N. et al. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288, 17954-67 (2013
36. Judd, L. M. et al. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. PLoS One 9, e95993 (2014
37. Stechishin, O. D. et al. On-Target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro Oncol 15, 198-207 (2013
38. Senft, C. et al. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101, 393-403 (2011
39. Guo, K. et al. Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Mol Cancer Ther 12, 264-273 (2013
40. Li, H. et al. STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice. PLoS One 6, e25941 (2011
41. Wang, J. et al. Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med 13, 3888-3897 (2009
42. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010
43. Saito, S. et al. Chemical genomics identifies the unfolded protein response as a target for seletcive cancer cell killing during glucose deprivation. Cancer Res 69, 4225-4234 (2009
44. Backer, J. M. et al. Chaperone-Targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Neoplasia 11, 1165-1173 (2009